BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16789453)

  • 1. Ethanol as a local adjuvant for giant cell tumor of bone.
    Jones KB; DeYoung BR; Morcuende JA; Buckwalter JA
    Iowa Orthop J; 2006; 26():69-76. PubMed ID: 16789453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
    Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
    Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
    Dürr HR; Maier M; Jansson V; Baur A; Refior HJ
    Eur J Surg Oncol; 1999 Dec; 25(6):610-8. PubMed ID: 10556009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
    ; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
    J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case analysis on treatment and recurrence of giant cell tumor of bone].
    Zhang Z; Zhu B; Sun T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
    Yacob O; Umer M; Gul M; Qadir I
    J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
    Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
    Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell tumor of bone. Curettage and cement reconstruction.
    Bini SA; Gill K; Johnston JO
    Clin Orthop Relat Res; 1995 Dec; (321):245-50. PubMed ID: 7497676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
    Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
    Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
    Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
    J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of benign giant cell tumours of bone in Singapore.
    Lim YW; Tan MH
    Ann Acad Med Singap; 2005 Apr; 34(3):235-7. PubMed ID: 15902343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study.
    Ke J; Cheng S; Yao MY; Chu X; Wang M; Zeng XL; Yang T; Zhang C; Zhong H; Zhang Y
    Orthop Surg; 2021 Feb; 13(1):185-195. PubMed ID: 33442922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone.
    Suzuki Y; Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Nakashima H; Ishiguro N
    Knee; 2007 Oct; 14(5):369-74. PubMed ID: 17601737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant.
    Oh JH; Yoon PW; Lee SH; Cho HS; Kim WS; Kim HS
    Int Orthop; 2006 Dec; 30(6):490-4. PubMed ID: 16736146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.
    Verdegaal SH; Brouwers HF; van Zwet EW; Hogendoorn PC; Taminiau AH
    J Bone Joint Surg Am; 2012 Jul; 94(13):1201-7. PubMed ID: 22760388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intralesional curettage and wide excision for treatment of giant cell tumors (GCTs) of the distal radius: A Meta-analysis].
    Yin ZC; Liu BG; Pang QJ; Chen XJ; Yu X
    Zhongguo Gu Shang; 2016 Jan; 29(1):58-64. PubMed ID: 27019899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative treatment of Campanacci grade III proximal humerus giant cell tumors.
    Lackman RD; Crawford EA; King JJ; Ogilvie CM
    Clin Orthop Relat Res; 2009 May; 467(5):1355-9. PubMed ID: 18987923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.